You have 9 free searches left this month | for more free features.

Condition

Acute Myeloid Leukemia (1)

Adenocarcinoma (1)

Carcinoma (1)

Hypernephroid (1)

Nephroid Carcinoma (1)

Renal Cell (1)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Bayside Health (1)

Novartis Pharmaceuticals (1)

Collaborator

Roche Pharma AG (1)

Intervention

rad001(everolimus) (2)

bevacizumab (1)

interferon alfa-2a (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

rad001(everolimus)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Carcinoma, Adenocarcinoma, Renal Cell Trial in Worldwide (RAD001(everolimus), interferon alfa-2a, bevacizumab)

Completed

Carcinoma
+4 more

RAD001(everolimus)
+2 more

Fayetteville, Arkansas
+107 more

Feb 13, 2017

Acute Myeloid Leukemia Trial in Melbourne (RAD001(Everolimus))

Unknown status

Acute Myeloid Leukemia

RAD001(Everolimus)

Melbourne, Victoria, Australia

BaysideHealth, The Alfred Hospital

Feb 12, 2013